维普中文期刊产品整合服务
88篇 您的检索式:作者名="Sweis"
    题名 作者 年代 出处 被引量
1Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: Implications of imatinib mesylate显示文摘瞄准:检验 imatinib 的影响耐心的幸存和反应和它的安全上的 mesylate (Glivec ) ,和反应的关联与工具包基因变化地位评价。方法:74 中的 33 个(44.6%) 在药品切除术以后并且不开发了复发的胃肠的基质肿瘤(大意) 病人与 Glivec 对待的小肠是被分类组 A 病人。与 Glivec 对待的 22 个先进的小肠大意病人作为组 B 病人被分类。Clinicopathological 特征,复发以后、全面的幸存率被比较。在组 B 病人的每个肿瘤为工具包或导出血小板的生长因素高山的变化被调查哈(PDGFRA ) 。变化类型与临床的结果被相关。在组 B 病人的 Glivec 的反肿瘤效果和安全也被估计。结果:与 Glivec 对待的先进的小肠大意病人比没与 Glivec 对待的那些有 substatntially 更长的复发以后的幸存和更高全面的幸存率。15 个病人的一个总数有部分回答(PR )(67.8%) 。c 工具包的激活的变化在 19 个测试病人中的 16 个被发现,没有 PDGFRA 异种被识别。在有在 11 个工具包变化上怀有前的大意的 13 个病人,部分反应率(PR ) 是 69.3% ,而有在 9 工具包变化上包含前的肿瘤的三个病人中的二个有 66.7% 的全面反应率(ORR )( 不重要) 。结论:Glivec 显著地与先进大意延长亚洲病人的复发以后、全面的幸存。Glivec 导致持续客观回答在多于有先进的小肠大意的亚洲病人的一半。11 上的工具包前的激活的变化在绝大多数大意是可检测的。在 11 个变化上处于为其大意在 9 上有工具包前的病人和前的 PR 率没有差别。Chun-Nan Yeh Tsung-Wen Chen Ting-Jung Wu Swei Hsueh Yi-Yin Jan 2006World Journal of Gastroenterology2006,12,23:6
2国际化妆品监管合作组织特别工作组关于个人护理产品中纳米技术应用的报告显示文摘1引言 国际化妆品监管合作组织(ICCR)是由美国、日本、欧盟和加拿大的化妆品政府监管主管部门组建的。这个多边框架组织的宗旨是在尽量减少国际贸易障碍的同时,给予全球消费者最高水平的保护。Jay Ansell Robert Bronaugh Luisa K.Carter Qasim Chaudhry Mark Lafranconi Tetsuji Nishimura Florian Schellauf Homer Swei Ian Tooley 姜宜凡 2011香料香精化妆品2011,,1:3
3An accurate technique for fixation in endoscopic brow lift 显示文摘McKirmey P Celetti S Sweis I 1996Plast Reeonstr Surg1996,97,4:1
4Upper esophageal sphincter and esophageal motility in patients with chronic cough and reflux: assessment by high-resolution manometry显示文摘Vardar R Sweis R Anggiansah A 2013Dis Esophagus2013,26,3:1
5Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Pro- longed Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Dis- ease显示文摘Penagini R Sweis R Mauro A 2015J Neurogastroenterol Motil2015,21,2:1
6Expression of transforming growth factor-β in human renal fibrosis显示文摘Chih-Wei yang Swei Hsueh mai-Szu wu 1997Nephron1997,7,:1
7A Six-degree-of-freedom micro-manipulator based on Piezoelectric translators显示文摘GAO Peng SWEI Shan-min 1999Nanotechnology1999,10,1:1
8A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain 显示文摘Sweis D Wong JC 2000Drug Safe2000,23,2:1
9Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps显示文摘Wong MS Erdmann D Sweis R 2004Plast Reconstr Surg2004,113,7:1
10Anew Piezodriven Precision Micropositioning Stage Utilizing Flexure Hinges显示文摘Peng Gao Shan-Min Swei and Zhejun Yun 1999Nanotechnology1999,10,:1
11A Six-Degree-of-Freedom Micro-Manipulator Based on Piezoelectric Translator显示文摘Peng Gao Shan-Min Swei 1999Nanotechnology1999,10,:1
12Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis显示文摘Linda L Hushaw Ray Sawaqed Ghaleb Sweis 2010Ther Clin Risk Manag2010,6,:1
13Oxidative Stress in the Dahl Hypertensive Rat显示文摘Allen Swei Fred Lacy Frank A. DeLano Geert W. Schmid-Schonbein 1997Hypertension1997,,6:1
14A new piazodriven precision micropositioning stage utilizing flexure hinges显示文摘Pend Gao Shanmin Swei Zhejun Yuan 1999Nanotechnology1999,,10:1
15A new piazodriven precision micropositioning stage utilizing flexure hinges显示文摘Pend Gao Shanmin Swei Zhejun Yuan 1999Nanotechnology1999,,10:1
16A new piezo-driven precision micro positioning stage utilizing flexure hinges显示文摘GAO Pend SWEI Shanmin YUAN Zhejun 1999Nanotechnology1999,,10:1
17The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease显示文摘Background:Aspirin-exacerbated respiratory disease(AERD)is an aggressive inflammatory disorder of the upper and lower respiratory tract.Corticosteroids,leukotriene modifiers,endoscopic sinus surgery(ESS),aspirin(ASA)desensitization,and biological immu-nomodulators are currently used to treat the disorder.Objective:The objective of this study was to determine the psychosocial impact of ESS and ASA desensitization on AERD patients.Methods:All AERD patients who underwent complete ESS were divided into two cohorts based on ASA desensitization status.The psychosocial metrics of the SNOT-22 were collected and analyzed at the following time points:pre-operative,1-month,3-month,6-month,and 12-month after ESS.Results:One hundred and eighty-four AERD patients underwent ESS from November 2009 to November 2018.From this group,130 patients underwent ASA desensitization(AD cohort)and 54 patients remained non-desensitized(ND cohort).AD patients showed a significantly greater reduction in total SNOT-22 scores over the study period compared to ND patients(p=0.0446).Analysis of SNOT-22 psychosocial metrics showed a significantly greater improvement in patient productivity in the AD cohort when compared to the ND cohort(p=0.0214).Further,a sub-group analysis accounting for subject attrition showed a significantly greater improvement in both productivity and concentration in AD patients when compared to the ND cohort(productivity:p=0.0068;concentration:p=0.0428).Conclusions:ESS followed by ASA desensitization decreases the overall psychosocial burden in AERD patients with a significant improvement in perceived productivity and concentration.This has significant implications given the psychosocial impact of chronic diseases.Tran Locke Auddie Sweis Theodore Lin Brian Sweis Patrick Gleeson Michael Kohanski Nithin Adappa James Palmer John Bosso 2020World Journal of Otorhinolaryngology-Head and Neck Surgery2020,6,4:1
18Laparoscopic hemi-hysterectomy in treatment of a didelphic uterus with a hypoplastic cervix and ovstructed hemivagina 显示文摘Lee CL Wang CJ Swei LD 1999Human Reproduction1999,14,:1
19Supramolecular metal organometallic coordination networks based on quinonoid complexes显示文摘Oh M Carpen G B Swei D A 2004Accounts of Chemical Research2004,37,1:1
20Laparoscopic hemi-hysterectomy in treatment of a didelphic uterus with a hypo-plastic cervix and ovstructed hemivagina 显示文摘Lee CL Wang C J Swei LD 1999Hum Reprod1999,14,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费